Table 4 Association of patient and human resource related factors with preference for ACT, Lokoja, North-Central Nigeria
Characteristics | No Preference for ACT, N = 244 n (%) | Preference for ACT, N = 160 n (%) | X2 | Unadjusted OR (95% CI) | p-value |
|---|---|---|---|---|---|
Drug treatment influenced by patients’ age | 223 (59.6) | 151 (40.4) | 0.9 | 1.6 (0.7–3.5) | 0.360 |
Drug treatment influenced by patients’ weight | 214 (59.4) | 146 (40.6) | 0.9 | 1.5 (0.8 – 2.9) | 0.340 |
Malaria severity influenced choice of antimalarial medicine | 206 (58.5) | 146 (41.5) | 3.4 | 1.9 (1.0 – 3.7) | 0.060 |
Patients' requests influenced choice of antimalarial medicine | 91 (62.8) | 54 (37.2) | 0.4 | 0.9 (0.6 – 1.3) | 0.530 |
Co-morbidity influenced choice of antimalarial medicine? | 161 (57.7) | 118 (42.3) | 2.4 | 1.5 (0.9 – 2.3) | 0.120 |
Patients' test results influenced choice of medicine | 207 (58.6) | 146 (41.4) | 3.05 | 1.86 (1.0 – 3.6) | 0.080 |
Patients’ ability to pay influenced antimalarial medicine given? | 113 (54.1) | 96 (45.9) | 6.71 | 1.7 (1.2 – 2.6) | 0.009* |
Treatment influenced by ACT advertisement | 86 (65.2) | 46 (34.8) | 2.6 | 0.7 (0.4 – 1.1) | 0.110 |
Medicines availability influenced drugs received by patients | 188 (57.1) | 141 (42.9) | 7.1 | 2.0 (1.3 – 3.9) | 0.007* |
Government-approval influenced choice of antimalarial medicine | 227 (59.7) | 153 (40.3) | 0.7 | 1.6 (0.7 – 4.0) | 0.390 |
Route of administration influenced choice of antimalarial medicine? | 149 (55.2) | 121 (44.8) | 8.6 | 2.0 (1.3 – 3.1) | 0.003* |
Previous training on malaria diagnosis and treatment guidelines | 122 (55.7) | 97 (44.3) | 1.6 | 1.0 – 2.4 | 0.039* |
Good knowledge of malaria case management | 84 (41.6) | 118 (58.4) | 5.4 | 3.4 – 8.3 | < 0.001* |